-
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Source: Buzz FX / 13 Mar 2025 02:31:17 America/Chicago
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Syndax Pharmaceuticals, Inc.
Read more...